Leana Wen

Insider Reports History

Entity
Individual
Location
C/O Glaukos Corporation, 229 Avenida Fabricante, San Clemente, CA
Signature
/s/ Jason D. Smith, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Leana Wen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GLAUKOS Corp Director Common Stock 18.2K $2.07M $113.68 May 30, 2024 Direct
GLAUKOS Corp Director Stock Option (Right to Buy) 1.25K $86.3K $69.30 May 30, 2024 Direct
UroGen Pharma Ltd. Director Stock Option (right ot buy) 10K Aug 6, 2024 Direct

Insider Reports Filed by Leana Wen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
URGN UroGen Pharma Ltd. Aug 6, 2024 1 $0 4 Aug 8, 2024 Director
GKOS GLAUKOS Corp May 30, 2024 2 $0 4 Jun 3, 2024 Director
URGN UroGen Pharma Ltd. Sep 7, 2023 1 $0 4 Sep 8, 2023 Director
GKOS GLAUKOS Corp Jun 1, 2023 1 $0 4 Jun 5, 2023 Director
GKOS GLAUKOS Corp Jan 3, 2023 1 $0 4 Jan 4, 2023 Director
GKOS GLAUKOS Corp Jan 3, 2023 1 $0 4 Jan 4, 2023 Director
URGN UroGen Pharma Ltd. Sep 8, 2022 0 $0 3 Sep 12, 2022 Director
URGN UroGen Pharma Ltd. Sep 8, 2022 1 $0 4 Sep 12, 2022 Director
GKOS GLAUKOS Corp Jun 2, 2022 1 $0 4 Jun 6, 2022 Director
GKOS GLAUKOS Corp Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
GKOS GLAUKOS Corp Jun 3, 2021 1 $0 4 Jun 7, 2021 Director